In recent years, induced protein degradation has become a powerful approach for chemical biology and drug discovery. In this lecture, I will present our research in the design of highly potent, selective, and in vivo efficacious degraders for a number of proteins targets, including those traditionally undruggable targets. These small-molecule degraders serve as powerful tools for targeting validation in vitro and in vivo and as promising lead compounds for clinical development of new therapeutic agents.